Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

217

HTML

2031

Tables (1-3)

186

Sum=2434

Jul 1, 2004 (publication date) through Nov 27, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Jul 1, 2004; 10(13): 1989-1991
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1989

Table 3 Mean survival time and increased life span (%ILS) after treatment (mean ± SD)

^aP < 0.05, vs FADR, ADR + NP;

^bP < 0.01, vs NS.

Citation: Chen JH, Ling R, Yao Q, Wang L, Ma Z, Li Y, Wang Z, Xu H. Enhanced antitumor efficacy on hepatoma-bearing rats with adriamycin-loaded nanoparticles administered into hepatic artery. World J Gastroenterol 2004; 10(13): 1989-1991
URL: https://www.wjgnet.com/1007-9327/full/v10/i13/1989.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i13.1989